Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance systemin Italy

Citation
A. Mele et al., Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance systemin Italy, J HEPATOL, 35(2), 2001, pp. 284-289
Citations number
30
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
JOURNAL OF HEPATOLOGY
ISSN journal
01688278 → ACNP
Volume
35
Issue
2
Year of publication
2001
Pages
284 - 289
Database
ISI
SICI code
0168-8278(200108)35:2<284:ROPTHF>2.0.ZU;2-#
Abstract
Background/Aims: To evaluate the strength of association between parenteral ly transmitted viral hepatitis and specific types of invasive procedures. Methods: Data from the surveillance system for type-specific acute viral he patitis (SEIEVA) during the period 1994-1999 were used. The association of acute hepatitis B virus (HBV) and hepatitis C virus (HCV) infection with th e potential risk factors (odds ratios (OR)) was estimated comparing 3120 he patitis B and 1023 hepatitis C cases with 7158 hepatitis A cases, used as c ontrols, by multiple logistic regression analysis. Results: Most procedures resulted in being associated with the risk of acqu iring acute HBV or HCV. The strongest associations were: for HBV infection, abdominal surgery (adjusted OR = 3.9; 95% confidence intervals (CI) = 2.0- 7.5), oral surgery (OR = 2.7; 95% CI = 1.6-4.5) and gynaecological surgery (OR = 2.6; 95% Cl = 1.2-5.5); for HCV infection, obstetric/gynaecological i nterventions (OR = 12.1; 95% CI = 5.6-26.3), abdominal surgery (OR = 7.0; 9 5% Cl = 3.2-14.9) and ophthalmological surgery (OR = 5.2; 95 % Cl = 1.1-23. 2). Biopsy and/or endoscopy were associated with HCV, but not with HBV infe ction. Conclusions: Invasive procedures represent an important mode of HBV and HCV transmission. Since a large proportion of the adult general population is exposed to these procedures and an effective HCV vaccine is not yet availab le, non-immunological means of controlling latrogenic modes of transmission are extremely important. (C) 2001 European Association for the Study of th e Liver. Published by Elsevier Science B.V. All rights reserved.